Piscataway, NJ, United States of America

Ashfaq Ahmed Parkar



Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ashfaq Ahmed Parkar: Innovator in Pharmaceutical Sciences

Introduction

Ashfaq Ahmed Parkar is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds and their applications in treating various diseases. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Among his latest patents is a groundbreaking invention related to Thienopyrazoles. This patent details the preparation of Thienopyrazoles of formula I, along with their pharmaceutical compositions and uses in modulating disease states through the inhibition of protein kinases, specifically interleukin-2 inducible tyrosine kinase (ITK). Another significant patent focuses on a novel member of the prostanoid receptor family, specifically a guinea pig prostaglandin D2 receptor. This patent describes the receptor, the nucleic acid that encodes it, and various potential uses for both.

Career Highlights

Ashfaq Ahmed Parkar is currently associated with Aventis Pharmaceuticals Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to advancing medical science and improving therapeutic options for patients.

Collaborations

Throughout his career, Ashfaq has collaborated with esteemed colleagues, including John G Jurcak and Matthieu Barrague. These collaborations have further enriched his research and development efforts.

Conclusion

In summary, Ashfaq Ahmed Parkar is a distinguished inventor whose work in pharmaceutical sciences has led to valuable patents and advancements in treatment methodologies. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…